Abstract
SUMOs are Small Ubiquitin-like Modifiers that are covalently conjugated to extensive sets of target proteins in cells to regulate their activity. A properly functioning sumoylation system is essential for eukaryotic life. The system comprises a set of conjugating enzymes known as E1, E2 and E3s and a set of deconjugating enzymes known as SENPs. Three mammalian SUMO family members have been identified, SUMO-1, SUMO-2 and SUMO-3. Sumoylation is involved in virtually all cellular processes including transcription, DNA damage response pathways, transport, ribosome biogenesis, pre-mRNA splicing, RNA editing and the cell cycle. Similar to ubiquitin, SUMOs form chains via internal sumoylation sites present in the flexible N-terminal parts of SUMO-2, SUMO-3 and the single SUMO family member in S. cerevisiae SMT3. SUMO-interacting proteins bind to mono- or poly-sumoylated proteins in a non-covalent manner to regulate the fate of sumoylated proteins. Sumoylation acts in concert with other post-translational modifications such as phosphorylation, acetylation and ubiquitination. In addition to SUMOs, the ubiquitin family consists of ISG15, NEDD8, ATG8, ATG12, FUBI, URM1, UFM1, FAT10, HUB1 and PUP. These protein modifiers play important roles in immunity, autophagy, ribosome biogenesis and other processes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Aos1:
-
Activation of Smt3p
- ATG8:
-
Autophagy-related protein 8
- ATG12:
-
Autophagy-related protein 12
- E1:
-
SUMO activating enzyme
- E2:
-
SUMO protein carrier protein
- E3:
-
SUMO ligase
- FAT10:
-
Ubiquitin-like protein FAT10
- FUBI:
-
Ubiquitin-like protein FUBI
- GMP1:
-
GAP-modifying protein 1
- HDAC:
-
Histone deacetylase
- HECT:
-
Homologous to the E6-AP carboxyl terminus
- HIF:
-
Hypoxia-inducible factor
- HUB1:
-
Ubiquitin-like modifier HUB1
- IκBα:
-
NFκB inhibitor α
- IR:
-
Internal repeats
- ISG15:
-
Interferon-stimulated gene 15
- Mdm2:
-
Mouse double minute 2
- NDSM:
-
Negatively charged amino acid-dependent sumoylation motif
- NEDD8:
-
Neural precursor cell expressed developmentally down-regulated protein 8
- NFκB:
-
Nuclear factor κB
- NPC:
-
Nuclear pore complex
- Pc2:
-
Polycomb protein 2
- PDSM:
-
Phosphorylation-dependent sumoylation motif
- PIAS:
-
Protein inhibitor of activated STAT
- PIC1:
-
PML-interacting clone 1
- PML:
-
Promyelocytic leukemia protein
- PUP:
-
Prokaryotic ubiquitin-like protein
- RanBP:
-
Ran-binding protein
- RanGAP:
-
Ran GTPase-activating protein
- RING:
-
Really interesting new gene
- RNF4:
-
RING finger protein 4
- SAE:
-
SUMO activating enzyme
- SENP:
-
SUMO protease
- SILAC:
-
Stable-isotope labeling by amino acids in cell culture
- SIM:
-
SUMO interaction motif
- Siz:
-
SAP and Miz-finger domain-containing protein 1
- SMT3:
-
Suppressor of mif two 3
- STAT:
-
Signal transducer and activator of transcription
- SUMO:
-
Small ubiquitin-like modifier
- TAF:
-
TBP-associated factor
- TBP:
-
TATA box binding protein
- TDG:
-
Thymine-DNA glycosylase
- Uba2:
-
Ubiquitin-activating enzyme E1-like
- Ubc9:
-
Ubiquitin carrier protein 9
- UBL1:
-
Ubiquitin-like protein 1
- UFM1:
-
Ubiquitin-fold modifier 1
- Ulp:
-
Ubiquitin-like-specific protease
- URM1:
-
Ubiquitin-related modifier 1
References
Andersen, J.S., Matic, I., and Vertegaal, A.C. (2009) Identification of SUMO target proteins by quantitative proteomics. Methods Mol. Biol. 497:19–31.
Andrews, E.A., Palecek, J., Sergeant, J., et al. (2005) Nse2, a component of the Smc5-6 complex, is a SUMO ligase required for the response to DNA damage. Mol. Cell. Biol. 25:185–196.
Baba, D., Maita, N., Jee, J.G., et al. (2005) Crystal structure of thymine DNA glycosylase conjugated to SUMO-1. Nature 435:979–982.
Bailey, D. and O’Hare, P. (2002) Herpes simplex virus 1 ICP0 co-localizes with a SUMO-specific protease. J. Gen. Virol. 83:2951–2964.
Bayer, P., Arndt, A., Metzger, S., et al. (1998) Structure determination of the small ubiquitin-related modifier SUMO-1. J. Mol. Biol. 280:275–286.
Bernier-Villamor, V., Sampson, D.A., and Matunis, M.J. (2002) Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell 108:345–356.
Boddy, M.N., Howe, K., Etkin, L.D., et al. (1996) PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene 13:971–982.
Boyer-Guittaut, M., Birsoy, K., Potel, C., et al. (2005) SUMO-1 modification of human transcription factor (TF) IID complex subunits: inhibition of TFIID promoter-binding activity through SUMO-1 modification of hsTAF5. J. Biol. Chem. 280:9937–9945.
Branzei, D., Sollier, J., Liberi, G., et al. (2006) Ubc9- and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks. Cell 127:509–522.
Bylebyl, G.R., Belichenko, I., and Johnson, E.S. (2003) The SUMO isopeptidase Ulp2 prevents accumulation of SUMO chains in yeast. J. Biol. Chem. 278:44113–44120.
Capili, A.D. and Lima, C.D. (2007) Structure and analysis of a complex between SUMO and Ubc9 illustrates features of a conserved E2-Ubl interaction. J. Mol. Biol. 369:608–618.
Catic, A., Fiebiger, E., Korbel, G.A., et al. (2007) Screen for ISG15-crossreactive deubiquitinases. PLoS ONE 2: e679.
Cheng, C.H., Lo, Y.H., Liang, S.S., et al. (2006) SUMO modifications control assembly of synaptonemal complex and polycomplex in meiosis of Saccharomyces cerevisiae. Genes Dev. 20:2067–2081.
Cheng, J., Kang, X., Zhang, S. et al. (2007) SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 131:584–595.
Chiu, S.Y., Asai, N., Costantini, F. et al. (2008) SUMO-specific protease 2 is essential for modulating p53-Mdm2 in development of trophoblast stem cell niches and lineages. PLoS Biol 6: e310.
Cooper, H.J., Tatham, M.H., Jaffray, E., et al. (2005) Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction. Anal. Chem. 77:6310–6319.
Dastur, A., Beaudenon, S., Kelley, M., et al. (2006) Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J. Biol. Chem. 281:4334–4338.
Dawlaty, M.M., Malureanu, L., Jeganathan, K.B., et al. (2008) Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. Cell 133:103–115.
Denison, C., Rudner, A.D., Gerber, S.A., et al. (2005) A proteomic strategy for gaining insights into protein sumoylation in yeast. Mol. Cell. Proteomics 4:246–254.
Desterro, J.M., Thomson, J., and Hay, R.T. (1997) Ubch9 conjugates SUMO but not ubiquitin. FEBS Lett. 417:297–300.
Desterro, J.M., Rodriguez, M.S., and Hay, R.T. (1998) SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell 2:233–239.
Desterro, J.M., Rodriguez, M.S., Kemp, G.D. et al. (1999) Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J. Biol. Chem. 274:10618–10624.
Ding, H., Xu, Y., Chen, Q., et al. (2005) Solution structure of human SUMO-3 C47S and its binding surface for Ubc9. Biochemistry 44:2790–2799.
Dobreva, G., Dambacher, J., and Grosschedl, R. (2003) SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. Genes Dev.17:3048–3061.
Dohmen, R.J., Stappen, R., McGrath, J.P., et al. (1995) An essential yeast gene encoding a homolog of ubiquitin-activating enzyme. J. Biol. Chem. 270:18099–18109.
Duprez, E., Saurin, A.J., Desterro, J.M., et al. (1999) SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J. Cell Sci. 112 (Pt 3):381–393.
Durfee, L.A., Kelley, M.L., and Huibregtse, J.M. (2008) The basis for selective E1-E2 interactions in the ISG15 conjugation system. J. Biol. Chem. 283:23895–23902.
Evdokimov, E., Sharma, P., Lockett, S.J., et al. (2008) Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3. J. Cell Sci. 121:4106–4113.
Geiss-Friedlander, R. and Melchior, F. (2007) Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell. Biol. 8:947–956.
Gill, G. (2005) Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 15:536–541.
Girdwood, D., Bumpass, D., Vaughan, O.A., et al. (2003) P300 transcriptional repression is mediated by SUMO modification. Mol.Cell 11:1043–1054.
Girdwood. D.W., Tatham, M.H., and Hay, R.T. (2004) SUMO and transcriptional regulation. Semin. Cell Dev. Biol. 15:201–210.
Gocke, C.B., Yu, H., and Kang, J. (2005) Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. J. Biol. Chem. 280:5004–5012.
Gong, L. and Yeh, E.T. (2006) Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. J. Biol. Chem. 281:15869–15877.
Gong, L., Kamitani, T., Fujise, K., et al. (1997) Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. J. Biol. Chem. 272: 28198–28201.
Gong, L., Millas, S., Maul, G.G., et al. (2000) Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J. Biol. Chem. 275:3355–3359.
Gregoire, S. and Yang, X.J. (2005) Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors. Mol. Cell. Biol. 25:2273–2287.
Haas, A.L., Ahrens, P., Bright, P.M. et al. (1987) Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J. Biol. Chem. 262:11315–11323.
Hang, J. and Dasso, M. (2002) Association of the human SUMO-1 protease SENP2 with the nuclear pore. J. Biol. Chem. 277:19961–19966.
Hannich, J.T., Lewis, A., Kroetz, M.B., et al. (2005) Defining the SUMO-modified proteome by multiple approaches in Saccharomyces cerevisiae. J. Biol. Chem. 280:4102–4110.
Hardeland, U., Steinacher, R., Jiricny, J. et al. (2002) Modification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnover. EMBO J. 21:1456–1464.
Hay, R.T. (2005) SUMO: a history of modification. Mol. Cell 18:1–12.
Hecker, C.M., Rabiller, M., Haglund, K., et al. (2006) Specification of SUMO1- and SUMO2-interacting motifs. J. Biol. Chem. 281:16117–16127.
Herrmann, J., Lerman, L.O., and Lerman, A. (2007) Ubiquitin and ubiquitin-like proteins in protein regulation. Circ. Res. 100:1276–1291.
Hietakangas, V., Anckar, J., Blomster, H.A., et al. (2006) PDSM, a motif for phosphorylation-dependent SUMO modification. Proc. Natl. Acad. Sci. USA 103:45–50.
Hoege, C., Pfander, B., Moldovan, G.L., et al. (2002) RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419:135–141.
Hori, T., Osaka, F., Chiba, T., et al. (1999) Covalent modification of all members of human cullin family proteins by NEDD8. Oncogene 18:6829–6834.
Huang, T.T., Wuerzberger-Davis, S.M., Wu, Z.H., et al. (2003) Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 115:565–576.
Hunter. T. (2007) The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol. Cell 28:730–738.
Ikeda, F. and Dikic, I. (2008) Atypical ubiquitin chains: new molecular signals. ‘Protein Modifications: Beyond the Usual Suspects’ review series. EMBO Rep. 9:536–542.
Johnson, E.S. (2004) Protein modification by SUMO. Annu. Rev. Biochem. 73:355–382.
Johnson, E.S. and Blobel, G. (1997) Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J. Biol. Chem. 272:26799–26802.
Johnson, E.S. and Gupta, A.A. (2001) An E3-like factor that promotes SUMO conjugation to the yeast septins. Cell 106:735–744.
Johnson, E.S, Schwienhorst, I., Dohmen, R.J., et al. (1997) The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J. 16:5509–5519.
Kagey, M.H., Melhuish, T.A., and Wotton, D. (2003) The polycomb protein Pc2 is a SUMO E3. Cell 113:127–137.
Kamitani, T., Kito, K., Nguyen, H.P., et al. (1998) Identification of three major sentrinization sites in PML. J. Biol. Chem. 273:26675–26682.
Kerscher, O., Felberbaum, R., and Hochstrasser, M. (2006) Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 22:159–180.
Knipscheer, P., van Dijk, W.J., Olsen, J.V., et al. (2007) Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation. EMBO J. 26:2797–2807.
Knipscheer, P., Flotho, A., Klug, H., et al. (2008) Ubc9 sumoylation regulates SUMO target discrimination. Mol. Cell 31:371–382.
Kumar, S., Tomooka, Y., and Noda, M. (1992) Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem. Biophys. Res. Commun. 185:1155–1161.
Lallemand-Breitenbach, V., Jeanne, M., Benhenda, S., et al. (2008) Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat. Cell Biol. 10:547–555.
Lee, G.W., Melchior, F., Matunis, M.J., et al. (1998) Modification of Ran GTPase-activating protein by the small ubiquitin-related modifier SUMO-1 requires Ubc9, an E2-type ubiquitin-conjugating enzyme homologue. J. Biol. Chem. 273:6503–6507.
Li, S.J. and Hochstrasser, M. (1999) A new protease required for cell-cycle progression in yeast. Nature 398:246–251.
Li, S.J. and Hochstrasser, M. (2000) The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein. Mol. Cell. Biol. 20:2367–2377.
Li, T., Evdokimov, E., Shen, R.F., et al. (2004) Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger proteins, and nuclear pore complex proteins: a proteomic analysis. Proc. Natl. Acad. Sci. USA 101:8551–8556.
Lin, D.Y., Huang, Y.S., Jeng, J.C., et al. (2006) Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell 24:341–354.
Liu, Y.C., Penninger, J., and Karin, M. (2005) Immunity by ubiquitylation: a reversible process of modification. Nat. Rev. Immunol. 5:941–952.
Lukasiak, S., Schiller, C., Oehlschlaeger, P., et al. (2008) Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene 27:6068–6074.
Mahajan, R., Delphin, C., Guan, T., et al. (1997) A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88: 97–107.
Mahajan, R., Gerace, L., and Melchior, F. (1998) Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association. J. Cell Biol. 140:259–270.
Makhnevych, T., Sydorskyy, Y., Xin, X., et al. (2009) Global map of SUMO function revealed by protein-protein interaction and genetic networks. Mol. Cell 33:124–135.
Malakhov, M.P., Malakhova, O.A., Kim, K.I., et al. (2002) UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 277:9976–9981.
Malakhov, M.P., Kim, K.I., Malakhova, O.A., et al. (2003) High-throughput immunoblotting. Ubiquitin-like protein ISG15 modifies key regulators of signal transduction. J. Biol. Chem. 278:16608–16613.
Mann, M. (2006) Functional and quantitative proteomics using SILAC. Nat. Rev. Mol. Cell. Biol. 7:952–958.
Manza, L.L., Codreanu, S.G., Stamer, S.L., et al. (2004) Global shifts in protein sumoylation in response to electrophile and oxidative stress. Chem. Res. Toxicol. 17: 1706–1715.
Matic, I., van Hagen, M., Schimmel, J., et al. (2008) In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol. Cell. Proteomics 7:132–144.
Matunis, M.J., Coutavas, E., and Blobel, G. (1996) A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135: 1457–1470.
Matunis, M.J., Wu, J., and Blobel, G. (1998) SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex. J. Cell Biol.140:499–509.
Mendoza, H.M., Shen, L.N., Botting, C., et al. (2003) NEDP1, a highly conserved cysteine protease that deNEDDylates Cullins. J. Biol. Chem. 278:25637–25643.
Meulmeester, E. and Melchior, F. (2008) Cell biology: SUMO. Nature 452:709–711.
Meulmeester, E., Kunze, M., Hsiao, H.H., et al. (2008) Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25. Mol. Cell 30:610–619.
Minty, A., Dumont, X., Kaghad, M., et al. (2000) Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J. Biol. Chem. 275:36316–36323.
Mizushima, N., Noda, T., Yoshimori, T., et al. (1998a) A protein conjugation system essential for autophagy. Nature 395:395–398.
Mizushima, N., Sugita, H., Yoshimori, T., et al. (1998b) A new protein conjugation system in human. The counterpart of the yeast Apg12p conjugation system essential for autophagy. J. Biol. Chem. 273:33889–33892.
Morimoto, M., Nishida, T., Honda, R., et al. (2000) Modification of cullin-1 by ubiquitin-like protein Nedd8 enhances the activity of SCF(skp2) toward p27(kip1). Biochem. Biophys. Res. Commun. 270:1093–1096.
Mossessova, E. and Lima, C.D. (2000) Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast. Mol. Cell 5:865–876.
Mukhopadhyay, D. and Dasso, M. (2007) Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 32:286–295.
Mukhopadhyay, D., Ayaydin, F., Kolli, N., et al. (2006) SUSP1 antagonizes formation of highly SUMO2/3-conjugated species. J. Cell Biol. 174:939–949.
Nacerddine, K., Lehembre, F., Bhaumik, M., et al. (2005) The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev. Cell 9:769–779.
Nathan, D., Ingvarsdottir, K., Sterner, D.E., et al. (2006) Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Genes Dev. 20:966–976.
Nishida, T., Tanaka, H., and Yasuda, H. (2000) A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase. Eur. J. Biochem. 267:6423–6427.
Ohsumi, Y. and Mizushima, N. (2004) Two ubiquitin-like conjugation systems essential for autophagy. Semin. Cell Dev. Biol. 15:231–236.
Okuma, T., Honda, R., Ichikawa, G., et al. (1999) In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2. Biochem. Biophys. Res. Commun. 254:693–698.
Okura, T., Gong, L., Kamitani, T., et al. (1996) Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J. Immunol. 157:4277–4281.
Osaka. F., Kawasaki, H., Aida, N., et al. (1998) A new NEDD8-ligating system for cullin-4A. Genes Dev. 12:2263–2268.
Pan, Z.Q., Kentsis, A., Dias, D.C., et al. (2004) Nedd8 on cullin: building an expressway to protein destruction. Oncogene 23:1985–1997.
Panse, V.G., Hardeland, U., Werner, T., et al. (2004) A proteome-wide approach identifies sumoylated substrate proteins in yeast. J. Biol. Chem. 279:41346–41351.
Papouli, E., Chen, S., Davies, A.A., et al. (2005) Crosstalk between SUMO and ubiquitin on PCNA is mediated by recruitment of the helicase Srs2p. Mol. Cell 19:123–133.
Pearce, M.J., Mintseris, J., Ferreyra, J., et al. (2008) Ubiquitin-like protein involved in the proteasome pathway of Mycobacterium tuberculosis. Science 322:1104–1107.
Pedrioli, P.G., Raught, B., Zhang, X.D., et al. (2006) Automated identification of SUMOylation sites using mass spectrometry and SUMmOn pattern recognition software. Nat. Methods 3:533–539.
Peng, J., Schwartz, D., Elias, J.E., et al. (2003) A proteomics approach to understanding protein ubiquitination. Nat. Biotechnol. 21:921–926.
Pfander, B., Moldovan, G.L., Sacher, M., et al. (2005) SUMO-modified PCNA recruits Srs2 to prevent recombination during S phase. Nature 436:428–433.
Pichler, A., Gast, A., Seeler, J.S., et al. (2002) The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108:109–120.
Pichler, A., Knipscheer, P., Saitoh, H., et al. (2004) The RanBP2 SUMO E3 ligase is neither. Nat. Struct. Mol. Biol. 11:984–991.
Pichler, A., Knipscheer, P., Oberhofer, E., et al. (2005) SUMO modification of the ubiquitin-conjugating enzyme E2-25K. Nat. Struct. Mol. Biol. 12:264–269.
Pitha-Rowe, I., Hassel, B.A., and Dmitrovsky, E. (2004) Involvement of UBE1L in ISG15 conjugation during retinoid-induced differentiation of acute promyelocytic leukemia. J. Biol. Chem. 279:18178–18187.
Potts, P.R. and Yu, H. (2005) Human MMS21/NSE2 is a SUMO ligase required for DNA repair. Mol. Cell Biol. 25:7021–7032.
Potts, P.R. and Yu, H. (2007) The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins. Nat. Struct. Mol. Biol. 14:581–590.
Prudden, J., Pebernard, S., Raffa, G., et al. (2007) SUMO-targeted ubiquitin ligases in genome stability. EMBO J. 26:4089–4101.
Rabut, G. and Peter, M. (2008) Function and regulation of protein neddylation. ‘Protein modifications: beyond the usual suspects’ review series. EMBO Rep. 9:969–976.
Reich, N., Evans, B., Levy, D., et al. (1987) Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc. Natl. Acad. Sci. USA 84:6394–6398.
Reverter. D. and Lima, C.D. (2004) A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex. Structure 12:1519–1531.
Ritchie, K.J. and Zhang, D.E. (2004) ISG15: the immunological kin of ubiquitin. Semin. Cell Dev. Biol. 15: 237–246.
Rodriguez, M.S., Desterro, J.M., Lain, S., et al. (1999) SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18:6455–6461.
Rodriguez, M.S., Dargemont, C., and Hay, R.T. (2001) SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276:12654–12659.
Rosas-Acosta, G., Langereis, M.A., Deyrieux, A., et al. (2005a) Proteins of the PIAS family enhance the sumoylation of the papillomavirus E1 protein. Virology 331:190–203.
Rosas-Acosta, G., Russell, W.K., Deyrieux, A., et al. (2005b) A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol. Cell. Proteomics 4:56–72.
Ross, S., Best, J.L., Zon, L.I., et al. (2002) SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol. Cell 10:831–842.
Roth, W., Sustmann, C., Kieslinger, M., et al. (2004) PIASy-deficient mice display modest defects in IFN and Wnt signaling. J. Immunol. 173:6189–6199.
Sachdev, S., Bruhn, L., Sieber, H., et al. (2001) PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15:3088–3103.
Saitoh, H. and Hinchey, J. (2000) Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275:6252–6258.
Saitoh, H., Sparrow, D.B., Shiomi, T., et al. (1998) Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2. Curr. Biol. 8:121–124.
Sampson, D.A., Wang, M., and Matunis, M.J. (2001) The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 276:21664–21669.
Santti, H., Mikkonen, L., Hirvonen-Santti, S., et al. (2003) Identification of a short PIASx gene promoter that directs male germ cell-specific transcription in vivo. Biochem. Biophys. Res. Commun. 308:139–147.
Schimmel, J., Larsen, K.M., Matic, I., et al. (2008) The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle. Mol. Cell. Proteomics 7:2107–2122.
Seufert, W., Futcher, B., and Jentsch, S. (1995) Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins. Nature 373:78–81.
Shalizi, A., Gaudilliere, B., Yuan, Z., et al. (2006) A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science 311:1012–1017.
Shen, Z., Pardington-Purtymun, P.E., Comeaux, J.C., et al. (1996) UBL1, a human ubiquitin-like protein associating with human RAD51/RAD52 proteins. Genomics 36: 271–279.
Shen, T.H., Lin, H.K., Scaglioni, P.P., et al. (2006) The mechanisms of PML-nuclear body formation. Mol. Cell 24:331–339.
Singer, J.D., Gurian-West, M., Clurman, B., et al. (1999) Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev. 13:2375–2387.
Song, J., Durrin, L.K., Wilkinson, T.A., et al. (2004) Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl. Acad. Sci. USA 101:14373–14378.
Stankovic-Valentin, N., Deltour, S., Seeler, J., et al. (2007) An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol. Cell. Biol. 27:2661–2675.
Steinacher, R. and Schar, P. (2005) Functionality of human thymine DNA glycosylase requires SUMO-regulated changes in protein conformation. Curr. Biol. 15:616–623.
Stelter, P. and Ulrich. H.D. (2003) Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation. Nature 425:188–191.
Sun, H., Leverson, J.D., and Hunter, T. (2007) Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins. EMBO J. 26:4102–4112.
Takahashi, Y., Mizoi, J., Toh, E., et al. (2000) Yeast Ulp1, an Smt3-specific protease, associates with nucleoporins. J. Biochem. 128:723–725.
Takahashi, H., Hatakeyama, S., Saitoh, H., et al. (2005) Noncovalent SUMO-1 binding activity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and colocalization with the promyelocytic leukemia protein. J. Biol. Chem. 280:5611–5621.
Tatham, M.H., Jaffray, E., Vaughan, O.A., et al. (2001) Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276:35368–35374.
Tatham, M.H., Geoffroy, M.C., Shen, L., et al. (2008) RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 10:538–546.
Ulrich, H.D. (2005) Mutual interactions between the SUMO and ubiquitin systems: a plea of no contest. Trends Cell Biol. 15:525–532.
Ulrich, H.D. (2008) The fast-growing business of SUMO chains. Mol. Cell 32:301–305.
Ulrich, H.D. (2009) The SUMO system: an overview. Methods Mol. Biol. 497:3–16.
Vertegaal, A.C. (2007) Small ubiquitin-related modifiers in chains. Biochem Soc. Trans. 35:1422–1423.
Vertegaal, A.C., Ogg, S.C., Jaffray, E., et al. (2004) A proteomic study of SUMO-2 target proteins. J. Biol. Chem. 279: 33791–33798.
Vertegaal, A.C., Andersen, J.S., Ogg, S.C., et al. (2006) Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol. Cell. Proteomics 5:2298–2310.
Weger, S., Hammer, E., and Heilbronn, R. (2005) Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo. FEBS Lett. 579:5007–5012.
Wilson, V.G. and Heaton, P.R. (2008) Ubiquitin proteolytic system: focus on SUMO. Expert Rev. Proteomics 5:121–135.
Wohlschlegel, J.A., Johnson, E.S., Reed, S.I., et al. (2004) Global analysis of protein sumoylation in Saccharomyces cerevisiae. J. Biol. Chem. 279:45662–45668.
Wong, K.A., Kim, R., Christofk, H., et al. (2004) Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life. Mol. Cell. Biol. 24:5577–5586.
Wong. J.J., Pung, Y.F., Sze, N.S., et al. (2006) HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc. Natl. Acad. Sci. USA 103:10735–10740.
Wu, K., Yamoah, K., Dolios, G., et al. (2003) DEN1 is a dual function protease capable of processing the C terminus of Nedd8 and deconjugating hyper-neddylated CUL1. J. Biol. Chem. 278:28882–28891.
Wykoff, D.D. and O’Shea, E.K. (2005) Identification of sumoylated proteins by systematic immunoprecipitation of the budding yeast proteome. Mol. Cell. Proteomics 4:73–83.
Xirodimas, D.P. (2008) Novel substrates and functions for the ubiquitin-like molecule NEDD8. Biochem. Soc. Trans. 36:802–806.
Xirodimas, D.P., Saville, M.K., Bourdon, J.C., et al. (2004) Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell 118:83–97.
Xu, Z. and Au, S.W. (2005) Mapping residues of SUMO precursors essential in differential maturation by SUMO-specific protease, SENP1. Biochem. J. 386:325–330.
Yang, S.H. and Sharrocks, A.D. (2004) SUMO promotes HDAC-mediated transcriptional repression. Mol. Cell 13:611–617.
Yang, S.H., Jaffray, E., Hay, R.T., et al. (2003) Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. Mol. Cell 12:63–74.
Yang, S.H., Galanis, A., Witty, J., et al. (2006) An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J. 25:5083–5093.
Zhang, H., Saitoh, H., and Matunis, M.J. (2002) Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol. Cell. Biol. 22:6498–6508.
Zhang, X.D., Goeres, J., Zhang, H., et al. (2008) SUMO-2/3 modification and binding regulate the association of CENP-E with kinetochores and progression through mitosis. Mol. Cell 29:729–741.
Zhao, X. and Blobel, G. (2005) A SUMO ligase is part of a nuclear multiprotein complex that affects DNA repair and chromosomal organization. Proc. Natl. Acad. Sci. USA 102:4777–4782.
Zhao, C., Beaudenon, S.L., Kelley, M.L., et al. (2004a) The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc. Natl. Acad. Sci. USA 101:7578–7582.
Zhao, Y., Kwon, S.W., Anselmo, A., et al. (2004b) Broad spectrum identification of cellular small ubiquitin-related modifier (SUMO) substrate proteins. J. Biol. Chem. 279: 20999–21002.
Zhou, W., Ryan, J.J., and Zhou, H. (2004) Global analyses of sumoylated proteins in Saccharomyces cerevisiae. Induction of protein sumoylation by cellular stresses. J. Biol. Chem. 279:32262–32268.
Zou, W. and Zhang, D.E. (2006) The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J. Biol. Chem. 281:3989–3994.
Acknowledgments
We are grateful to Joost Schimmel, Ivo Hendriks and Sarah Sparks for critically reading the manuscript. We thank Ivo Hendriks for preparing Table 13.1. We apologise to colleagues whose work was not cited due to space constrains. Research in the laboratory of ACOV is supported by the Netherlands Organisation for Scientific Research (NWO).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
van Hagen, M., Vertegaal, A.C.O. (2011). Small Ubiquitin-Like Modifiers and Other Ubiquitin-Like Proteins. In: Vidal, C. (eds) Post-Translational Modifications in Health and Disease. Protein Reviews, vol 13. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6382-6_13
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6382-6_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6381-9
Online ISBN: 978-1-4419-6382-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)